SpringWorks Therapeutics Inc (SWTX) — Cash Flow Reinvestment Rate

Latest as of December 2020: 14.79x

SpringWorks Therapeutics Inc (SWTX) has a Cash Flow Reinvestment Rate of 14.79x as of December 2020, reinvesting $222.84 Million (capex $54.00K plus investments $-222.78 Million) from operating cash flow of $15.07 Million. Check SpringWorks Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

14.79x
(Capex + Investments) / Operating CF

Total Reinvested

$222.84 Million
Capex + Investments

Operating Cash Flow

$15.07 Million
USD

Capital Expenditures

$54.00K
USD

SpringWorks Therapeutics Inc Cash Flow Reinvestment Rate (2000–2010)

Historical reinvestment intensity for SpringWorks Therapeutics Inc across 9 annual periods. Explore SWTX long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for SpringWorks Therapeutics Inc (2000–2010)

Year-by-year capital reinvestment analysis for SpringWorks Therapeutics Inc. For live market cap and broader valuation context, see SpringWorks Therapeutics Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2010 0.34x $1.89 Million $5.61 Million $1.89 Million ▲ +2.1%
2009 0.33x $1.73 Million $5.23 Million $1.73 Million ▲ +274.2%
2008 0.09x $626.00K $7.10 Million $626.00K ▼ -29.3%
2007 0.12x $710.00K $5.70 Million $710.00K ▼ -92.2%
2006 1.59x $1.19 Million $748.00K $1.19 Million ▲ +733.4%
2005 0.19x $766.00K $4.01 Million $766.00K ▲ +91.7%
2004 0.10x $382.00K $3.83 Million $382.00K
2001 0.00x $0.00 $13.79 Million $0.00
2000 0.00x $0.00 $1.59 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow